Related references
Note: Only part of the references are listed.Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids
Donatella Delle Cave et al.
THERANOSTICS (2021)
Cancer stem cells and their unique role in metastatic spread
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2020)
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
Nastassja Terraneo et al.
CANCERS (2020)
Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets
Luise Mueller et al.
FRONTIERS IN IMMUNOLOGY (2020)
Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells
Marco Giordano et al.
JOURNAL OF CLINICAL MEDICINE (2020)
An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
Mei-Yu Quan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation
Donatella Dellle Cave et al.
ONCOGENE (2020)
TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
Ruth M. Escalona et al.
BMC CANCER (2020)
STAT3 signaling in ovarian cancer: a potential therapeutic target
Renba Liang et al.
JOURNAL OF CANCER (2020)
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer
Karuna Ganesh et al.
NATURE CANCER (2020)
Novel activators and small-molecule inhibitors of STAT3 in cancer
Lehe Yang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
FGF Signalling in the Self-Renewal of Colon Cancer Organoids
Joerg Otte et al.
SCIENTIFIC REPORTS (2019)
A Fragment of Adhesion Molecule L1 Binds to Nuclear Receptors to Regulate Synaptic Plasticity and Motor Coordination
Kristina Kraus et al.
MOLECULAR NEUROBIOLOGY (2018)
CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
Michela Lupia et al.
STEM CELL REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
IL-6 mediates platinum -induced enrichment of ovarian cancer stem cells
Yinu Wang et al.
JCI INSIGHT (2018)
Ovarian cancer stem cells: still an elusive entity?
Michela Lupia et al.
MOLECULAR CANCER (2017)
DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
Riikka J. Lund et al.
SCIENTIFIC REPORTS (2017)
Cancer stem cells: at the forefront of personalized medicine and immunotherapy
Micol E. Fiorit et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Tatsuya Ishiguro et al.
CANCER SCIENCE (2017)
Management of relapsed ovarian cancer: a review
Gonzalo H. Giornelli
SPRINGERPLUS (2016)
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
Cai M. Roberts et al.
SCIENTIFIC REPORTS (2016)
Elevated AKAP12 in Paclitaxel-Resistant Serous Ovarian Cancer Cells Is Prognostic and Predictive of Poor Survival in Patients
Nicholas W. Bateman et al.
JOURNAL OF PROTEOME RESEARCH (2015)
CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
Daniela Burgos-Ojeda et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Youzhi Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Khalid Abubaker et al.
BMC CANCER (2014)
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization
Elena Magrini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor
Vishnu Mohanan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation
S. Bondong et al.
ANNALS OF ONCOLOGY (2012)
Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival
C. H. Choi et al.
BRITISH JOURNAL OF CANCER (2012)
Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma
Heiner Schaefer et al.
CANCER LETTERS (2012)
EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation
Helena Kiefel et al.
CARCINOGENESIS (2012)
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
Balazs Gyoerffy et al.
ENDOCRINE-RELATED CANCER (2012)
Generation and Nuclear Translocation of Sumoylated Transmembrane Fragment of Cell Adhesion Molecule L1
David Lutz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
L1CAM A major driver for tumor cell invasion and motility
Helena Kiefel et al.
CELL ADHESION & MIGRATION (2012)
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
Lin Cheng et al.
EMBO JOURNAL (2011)
Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity
Svenja Riedle et al.
BIOCHEMICAL JOURNAL (2009)
The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking
Chiara Francavilla et al.
JOURNAL OF CELL BIOLOGY (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Control of Stemness by Fibroblast Growth Factor Signaling in Stem Cells and Cancer Stem Cells
Noriko Gotoh
CURRENT STEM CELL RESEARCH & THERAPY (2009)
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium
Silvia Zeechini et al.
CANCER RESEARCH (2008)
Fibronectin type III (FN3) modules of the neuronal cell adhesion molecule L1 interact directly with the fibroblast growth factor (FGF) receptor
Nikolaj Kulahin et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells
Alexander Stoeck et al.
GYNECOLOGIC ONCOLOGY (2007)
Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration
Patricia F. Maness et al.
NATURE NEUROSCIENCE (2007)
Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment
MJE Arlt et al.
CANCER RESEARCH (2006)
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
U Cavallaro et al.
NATURE REVIEWS CANCER (2004)
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas
M Fogel et al.
LANCET (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain
SJ Schreiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling
RA Blake et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects
SD Skaper et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
